AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 64 filers reported holding AVROBIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,209 | +24430.6% | 9,876 | +15093.8% | 0.00% | – |
Q2 2023 | $62 | -4.6% | 65 | 0.0% | 0.00% | – |
Q1 2023 | $65 | +41.3% | 65 | 0.0% | 0.00% | – |
Q4 2022 | $46 | -99.7% | 65 | -99.7% | 0.00% | – |
Q3 2022 | $14,000 | +366.7% | 22,431 | +805.9% | 0.00% | – |
Q1 2022 | $3,000 | -84.2% | 2,476 | -50.4% | 0.00% | – |
Q4 2021 | $19,000 | +72.7% | 4,987 | +149.4% | 0.00% | – |
Q3 2021 | $11,000 | -79.2% | 2,000 | -66.7% | 0.00% | – |
Q2 2021 | $53,000 | +1225.0% | 6,000 | +1691.0% | 0.00% | – |
Q1 2021 | $4,000 | -84.6% | 335 | -81.8% | 0.00% | – |
Q4 2020 | $26,000 | +30.0% | 1,843 | +56.5% | 0.00% | – |
Q2 2020 | $20,000 | -99.2% | 1,178 | -99.3% | 0.00% | -100.0% |
Q1 2020 | $2,600,000 | +9529.6% | 167,076 | +12557.3% | 0.00% | – |
Q4 2019 | $27,000 | -96.4% | 1,320 | -97.5% | 0.00% | – |
Q3 2019 | $759,000 | -18.8% | 53,784 | -6.5% | 0.00% | – |
Q2 2019 | $935,000 | +10.0% | 57,502 | +49.2% | 0.00% | – |
Q1 2019 | $850,000 | +21150.0% | 38,549 | +18256.7% | 0.00% | – |
Q4 2018 | $4,000 | -95.3% | 210 | -87.3% | 0.00% | – |
Q3 2018 | $86,000 | +72.0% | 1,657 | -5.3% | 0.00% | – |
Q2 2018 | $50,000 | – | 1,749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |